四君子汤加减合桂枝茯苓丸治疗子宫肌瘤的临床研究
摘 要 目的:探讨四君子汤加减联合桂枝茯苓丸对子宫肌瘤患者激素水平、免疫功能及血清糖类抗原125(CA125)、血管内皮生长因子(VEGF)表达的影响。方法:将141例子宫肌瘤患者随机分为对照组(n=70)和观察组(n=71),对照组采用西医常规治疗,观察组在此基础上给以四君子汤加减和桂枝茯苓丸的联合治疗,比较两组临床疗效。结果:观察组总有效率和免疫功能指标高于对照组;激素水平、VEGF以及CA125的表达水平低于对照组(均P<0.05)。结论:四君子汤加减联合桂枝茯苓丸治疗子宫肌瘤可有效改善患者的免疫功能和激素水平,下调CA125和VEGF的表达。关键词 四君子汤 桂枝茯苓丸 CA125 免疫功能 激素
中图分类号:R271.9; R711.74 文献标志码:A 文章编号:1006-1533(2022)09-0023-04
引用本文 王春红. 四君子汤加减合桂枝茯苓丸治疗子宫肌瘤的临床研究[J]. 上海医药, 2022, 43(9): 23-26.
Clinical study on Sijunzi decoction combined with Guizhi Fuling pill in the treatment of hysteromyoma
WANG Chunhong(Department of Hospital-Acquired Infection Control, the Third People’s Hospital of He’nan Province, Zhengzhou 450000, China)
ABSTRACT Objective: To explore the effect of Sijunzi decoction combined with Guizhi Fuling pill on the hormone level, immune function and the expression level of carbohydrate antigen 125 (CA125) and vascular endothelial growth factor(VEGF) in patients with hysteromyoma. Methods: One hundred and forty-one patients with hysteromyoma were randomly divided into a control group (n=70) and an observation group (n=71). The control group was treated with conventional therapy of western medicine ......
您现在查看是摘要页,全文长 10510 字符。